Theralase Technologies(TSE:TLT)
CA$0.190.00 (0.00%)
TSE:TLT
Theralase Technologies financials statements
CA$0.19
At close:0.00 (0.00%)
Want to see TSE:TLT full AI Analyst Report?
Theralase Technologies (TLT) Financial Statements
99 Followers
Theralase Technologies Financial Overview
Theralase Technologies's market cap is currently C$57.44M. The company's EPS TTM is C$-0.01; its P/E ratio is -13.03; Theralase Technologies is estimated to report earnings on December 2, 2026, and the estimated EPS forecast is C$-0.00. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Dec 24 | Dec 23 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 816.47K | C$ 1.03M | C$ 1.07M | C$ 1.14M | C$ 780.64K |
| Gross Profit | C$ 241.51K | C$ 554.03K | C$ 562.13K | C$ 628.17K | C$ 309.94K |
| Operating Income | C$ -4.18M | C$ -4.29M | C$ -4.59M | C$ -5.20M | C$ -4.52M |
| EBITDA | C$ -3.91M | C$ -3.96M | C$ -4.25M | C$ -4.90M | C$ -4.31M |
| Net Income | C$ -4.12M | C$ -4.26M | C$ -4.57M | C$ -5.25M | C$ -4.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 182.91K | C$ 268.76K | C$ 43.91K | C$ 1.51M | C$ 3.69M |
| Total Assets | C$ 3.49M | C$ 3.25M | C$ 3.28M | C$ 4.16M | C$ 5.94M |
| Total Debt | C$ 458.05K | C$ 293.87K | C$ 386.88K | C$ 473.62K | C$ 35.72K |
| Net Debt | C$ 275.14K | C$ 25.11K | C$ 342.97K | C$ -1.03M | C$ -3.66M |
| Total Liabilities | C$ 1.72M | C$ 1.18M | C$ 1.37M | C$ 1.07M | C$ 874.79K |
| Stockholders' Equity | C$ 1.78M | C$ 2.07M | C$ 1.91M | C$ 3.09M | C$ 5.07M |
| Cash Flow | |||||
| Free Cash Flow | C$ -3.33M | C$ -3.35M | C$ -4.11M | C$ -5.20M | C$ -4.13M |
| Operating Cash Flow | C$ -3.29M | C$ -3.33M | C$ -4.07M | C$ -5.13M | C$ -4.03M |
| Investing Cash Flow | C$ -48.94K | C$ -19.97K | C$ -37.27K | C$ -70.41K | C$ -100.82K |
| Financing Cash Flow | C$ 3.25M | C$ 3.57M | C$ 2.65M | C$ 3.02M | C$ -57.37K |
Currency in CAD
